{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:44:14Z","timestamp":1785908654840,"version":"3.56.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mild autonomous cortisol secretion (MACS) is associated with an increased cardiovascular mortality, but even patients with non-functioning adrenal adenoma (NFA) might be at risk for cardio-metabolic comorbidities compared to a control group with absence of an adrenal tumor (CON).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and methods<\/jats:title>\n                    <jats:p>\n                      Seventyfour individuals were included in cross-sectional analysis [MACS: n=25(84% females), age: 63(55-67)years, BMI:27.00(24.20-30.50)kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      ; NFA: n=25(84%females), age: 61(54-68)years, BMI:28.50(27.50-32.20)kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      and CON: n=24 (75%females), age: 58 (51-64)years, BMI: 27.39(22.03-30.17) kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      ]. Visceral and ectopic fat stores, as well as heart function were assessed by magnetic resonance imaging and spectroscopy. Blood pressure was measured by standardized protocols. Blood was drawn in the fasting state and during an oral glucose tolerance test to assess glucose and lipid metabolism.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The prevalence of hypertension (MACS:84%\n                      <jats:italic>vs<\/jats:italic>\n                      NFA:76%\n                      <jats:italic>vs<\/jats:italic>\n                      CON: 43.5%), dyslipidemia (MACS:96%\n                      <jats:italic>vs<\/jats:italic>\n                      NFA:80%\n                      <jats:italic>vs<\/jats:italic>\n                      CON:62.5%) and prediabetes (MACS:56%\n                      <jats:italic>vs<\/jats:italic>\n                      . NFA:72%\n                      <jats:italic>vs<\/jats:italic>\n                      CON:29.2%) was significantly different between the groups. Markers of glucose metabolism were worse in MACS and best in CON (HbA1c: 5.70 (5.40-5.90)%\n                      <jats:italic>vs<\/jats:italic>\n                      5.50 (5.40-5.80)%\n                      <jats:italic>vs<\/jats:italic>\n                      5.40 (5.27-5.60)%, p=0.043); HOMA_IR:2.91(2.19-4.15)\n                      <jats:italic>vs<\/jats:italic>\n                      2.55 (1.57- 4.97)\n                      <jats:italic>vs<\/jats:italic>\n                      1.73 (1.00-2.61), p=0.007). epicardial adipose tissue area was highest in MACS patients, followed by NFA, with lowest values in CON (MACS:1159.68 (930.38-1454.11) mm\n                      <jats:sup>2<\/jats:sup>\n                      <jats:italic>vs<\/jats:italic>\n                      NFA: 873.23 (638.03-1195.33) mm\n                      <jats:sup>2<\/jats:sup>\n                      <jats:italic>vs<\/jats:italic>\n                      CON:672.37 (549.44-890.30) mm\n                      <jats:sup>2<\/jats:sup>\n                      , p&amp;lt;0.001). No relevant between-group-differences in cardiac morphology, intramyocardial fat or intrahepatic fat were observed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this exploratory study, MACS was associated with epicardial adiposity and an adverse cardio-metabolic risk profile.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1898271","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:48:07Z","timestamp":1785905287000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Adverse cardio-metabolic risk profile and epicardial adiposity in patients with adrenal adenoma: a cross-sectional study"],"prefix":"10.3389","volume":"17","author":[{"given":"Helena","family":"Niziolek","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivica","family":"Just","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tosin","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Baumgartner","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Koldyka","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"K\u00f6rm\u00f6czi","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Fellinger","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannes","family":"Beiglb\u00f6ck","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luise","family":"Bellach","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Domenig","sequence":"additional","affiliation":[{"name":"Attoquant Diagnostics","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Zeyda","sequence":"additional","affiliation":[{"name":"Division of Pediatric Pulmonology, Allergology and Endocrinology, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansj\u00f6rg","family":"Habisch","sequence":"additional","affiliation":[{"name":"Division of Medicinal Chemistry, Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Medical University of Graz","place":["Graz, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Madl","sequence":"additional","affiliation":[{"name":"Division of Medicinal Chemistry, Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Medical University of Graz","place":["Graz, Austria"]},{"name":"BioTechMed-Graz","place":["Graz, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Luger","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greisa","family":"Vila","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siegfried","family":"Trattnig","sequence":"additional","affiliation":[{"name":"Department of Biomedical Imaging and Image Guided Therapy, Medical University of Vienna","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Kautzky-Willer","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Scherer","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Leutner","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Krebs","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Krssak","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wolf","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-024-00984-y","article-title":"Mild autonomous cortisol secretion: pathophysiology, comorbidities and management approaches","volume":"20","author":"Prete","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"189","author":"Fassnacht","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1093\/ejendo\/lvad134","article-title":"Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis","volume":"189","author":"Pelsma","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.7326\/M16-0547","article-title":"\u2018Nonfunctional\u2019 adrenal tumors and the risk for incident diabetes and cardiovascular outcomes: a cohort study","volume":"165","author":"Lopez","year":"2016","journal-title":"Ann Intern Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2023.2442","article-title":"Mortality in patients with nonfunctional adrenal tumors","volume":"183","author":"Patrova","year":"2023","journal-title":"JAMA Intern Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1530\/endoabs.59.p015","article-title":"Natural history of adrenal incidentalomas with and without mild autonomous cortisol excess: a systematic review and meta-analysis","volume":"171","author":"Elhassan","year":"2019","journal-title":"Ann Intern Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/s2213-8587(22)00100-0","article-title":"Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study","volume":"10","author":"Deutschbein","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.7326\/m20-7946","article-title":"Association between mortality and levels of autonomous cortisol secretion by adrenal incidentalomas: a cohort study","volume":"174","author":"Kjellbom","year":"2021","journal-title":"Ann Intern Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000099542.57313.c5","article-title":"Human epicardial adipose tissue is a source of inflammatory mediators","volume":"108","author":"Mazurek","year":"2003","journal-title":"Circulation"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.113.000582","article-title":"Epicardial and perivascular adipose tissues and their influence on cardiovascular disease: basic mechanisms and clinical associations","volume":"3","author":"Fitzgibbons","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.03.509","article-title":"Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium","volume":"71","author":"Packer","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab556","article-title":"Epicardial and pericardial adiposity without myocardial steatosis in Cushing syndrome","volume":"106","author":"Wolf","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.07.096","article-title":"Cushing syndrome is associated with subclinical LV dysfunction and increased epicardial adipose tissue","volume":"72","author":"Maurice","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.55730\/1300-0144.5360","article-title":"Assessment of subclinical cardiovascular alterations in nonfunctioning adrenal incidentalomas","volume":"52","author":"Can","year":"2022","journal-title":"Turk J Med Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-013-9902-5","article-title":"Epicardial fat thickness and left ventricular mass in subjects with adrenal incidentaloma","volume":"44","author":"Iacobellis","year":"2013","journal-title":"Endocrine"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.5812\/ijem.37635","article-title":"The relationship between increased epicardial fat thickness and left ventricular hypertrophy and carotid intima-media thickness in patients with nonfunctional adrenal incidentaloma","volume":"14","author":"Imga","year":"2016","journal-title":"Int J Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41586-019-1797-8","article-title":"The integrative biology of type 2 diabetes","volume":"576","author":"Roden","year":"2019","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1201\/9781315382883-6","article-title":"Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study","volume":"116","author":"McGavock","year":"2007","journal-title":"Circulation"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/oby.24153","article-title":"Sex differences in ectopic lipid deposits and cardiac function across a wide range of glycemic control: a secondary analysis","volume":"32","author":"Harreiter","year":"2024","journal-title":"Obesity"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/ep171764.appgl","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease","volume":"23","author":"Jellinger","year":"2017","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/ijpo.12739","article-title":"A branched-chain amino acid-based metabolic score can predict liver fat in children and adolescents with severe obesity","volume":"16","author":"Lischka","year":"2021","journal-title":"Pediatr Obes"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/75.3.453","article-title":"Body-composition assessment via air-displacement plethysmography in adults and children: a review","volume":"75","author":"Fields","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1530\/ec-24-0617","article-title":"Mineralocorticoid axis activity and cardiac remodeling in patients with ACTH-dependent Cushing\u2019s syndrome","volume":"14","author":"Wolf","year":"2025","journal-title":"Endocr Connect"},{"key":"B24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1530\/eje-19-0086","article-title":"Identifying a disease-specific renin-angiotensin-aldosterone system fingerprint in patients with primary adrenal insufficiency","volume":"181","author":"Wolf","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091607","article-title":"Hepatic rather than cardiac steatosis relates to glucose intolerance in women with prior gestational diabetes","volume":"9","author":"Winhofer","year":"2014","journal-title":"PloS One"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-011-2146-0","article-title":"Insulin resistance is not associated with myocardial steatosis in women","volume":"54","author":"Kr\u0161\u0161\u00e1k","year":"2011","journal-title":"Diabetologia"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151301","article-title":"Pericardial- rather than intramyocardial fat is independently associated with left ventricular systolic heart function in metabolically healthy humans","volume":"11","author":"Wolf","year":"2016","journal-title":"PloS One"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2024.0080","article-title":"Cardiovascular significance and genetics of epicardial and pericardial adiposity","volume":"9","author":"R\u00e4m\u00f6","year":"2024","journal-title":"JAMA Cardiol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2025.02.006","article-title":"Uncovering the role of prokineticin pathway on epicardial adipose tissue (EAT) development and EAT-associated cardiomyopathy","volume":"35","author":"Vincenzi","year":"2025","journal-title":"Trends Cardiovasc Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1007\/s40618-023-02295-x","article-title":"Epicardial and pericoronary adipose tissue and coronary plaque burden in patients with Cushing\u2019s syndrome: a propensity score-matched study","volume":"47","author":"Wang","year":"2024","journal-title":"J Endocrinol Invest"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.11.062","article-title":"Association of epicardial fat with cardiovascular risk factors and incident myocardial infarction in the general population: the Heinz Nixdorf Recall Study","volume":"61","author":"Mahabadi","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41569-022-00679-9","article-title":"Epicardial adipose tissue in contemporary cardiology","volume":"19","author":"Iacobellis","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1093\/eurheartj\/eht099","article-title":"Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines","volume":"36","author":"Venteclef","year":"2015","journal-title":"Eur Heart J"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-024-10478-8","article-title":"Epicardial adipose tissue: a new link between type 2 diabetes and heart failure-a comprehensive review","volume":"30","author":"Zhang","year":"2025","journal-title":"Heart Fail Rev"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077326","article-title":"Adequately adapted insulin secretion and decreased hepatic insulin extraction cause elevated insulin concentrations in insulin resistant non-diabetic adrenal incidentaloma patients","volume":"8","author":"Anderwald","year":"2013","journal-title":"PloS One"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-0295-5","article-title":"Hyperinsulinaemia in cancer","volume":"20","author":"Gallagher","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2026.103775","article-title":"Metabolic effects of metyrapone treatment in patients with mild autonomous cortisol secretion: a prospective proof-of-concept trial","volume":"92","author":"Niziolek","year":"2026","journal-title":"eClinicalMedicine"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(24)01811-7","article-title":"Steatotic liver disease","volume":"404","author":"Israelsen","year":"2024","journal-title":"Lancet Lond Engl"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-1983","article-title":"Gluconeogenesis, but not glycogenolysis, contributes to the increase in endogenous glucose production by SGLT-2 inhibition","volume":"44","author":"Wolf","year":"2021","journal-title":"Diabetes Care"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1898271\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:48:14Z","timestamp":1785905294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1898271\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":40,"alternative-id":["10.3389\/fendo.2026.1898271"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1898271","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"article-number":"1898271"}}